Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001193125-26-208632

EVP and Chief Medical Officer sold 344 shares at $24.96 ($8,586)

From the SEC's structured data for this filing

Trades in this filing

Crombez Eric · EVP and Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-05 Sale : show line 1 in the form −344 $24.96 $8,586 111,189 D
Open-market sales · 344 sh · avg $24.96 · $8,586
Loading xslF345X06/ownership.xml…